Abstract:Protein expression systems are widely used in biotechnology and medicine for the efficient and economic production of therapeutic proteins. Today, cultivated Chinese hamster ovary (CHO) cells are the market dominating mammalian cell-line for the production of complex therapeutic proteins. Despite this outstanding potential of CHO cells, no high-yield cell-free system based on translationally active lysates from these cells has been reported so far. To date, CHO cell extracts have only been used as a foundational research tool for understanding mRNA translation (Lodish et al., 1974; McDowell et al., 1972). In the present study, we address this fact by establishing a novel cell-free protein expression system based on extracts from cultured CHO cells. Lysate preparation, adaptation of in vitro reaction conditions and the construction of particular expression vectors are considered for high-yield protein production. A specific in vitro expression vector, which includes an internal ribosome entry site (IRES) from the intergenic region (IGR) of the Cricket paralysis virus (CrPV), has been constructed in order to obtain optimal performance. The IGR IRES is supposed to bind directly to the eukaryotic 40S ribosomal subunit thereby bypassing the process of translation initiation, which is often a major bottleneck in cell-free systems. The combination of expression vector and optimized CHO cell extracts enables the production of approximately 50 µg/mL active firefly luciferase within 4 h. The batch-type cell-free coupled transcription-translation system has the potential to perform post-translational modifications, as shown by the glycosylation of erythropoietin. Accordingly, the system contains translocationally active endogenous microsomes, enabling the co-translational incorporation of membrane proteins into biological membranes. Hence, the presented in vitro translation system is a powerful tool for the fast and convenient optimization of expression constructs, the specific labeling of integral membrane proteins and the cell-free production of posttranslationally modified proteins.

Retrovectors packaged in CHO cells to generate GLP-1-Fc stable expression CHO cell lines

CRISPR-Cas9 Mediated Stable Expression of Exogenous Proteins in the CHO Cell Line through Site-Specific Integration

Construction and application of a multifunctional CHO cell platform utilizing Cre/ lox and Dre/ rox site-specific recombination systems

A highly efficient transposon vector system for recombinant protein expression in CHO cells

A New-Generation Stable Inducible Packaging Cell Line for Lentiviral Vectors.

Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35

Enhanced Biosynthesis Performance of Heterologous Proteins in CHO-K1 Cells Using CRISPR-Cas9

Optimization of a novel expression system for recombinant protein production in CHO cells

Construction of a CHO cell line with site-specific integration to stably express exogenous proteins using the CRISPR–Cas9 technique

Cell‐free protein expression based on extracts from CHO cells

Enhancing stability of recombinant CHO cells by CRISPR/Cas9-mediated site-specific integration into regions with distinct histone modifications

[Sorting of Packaging Cells for Retroviral Vector Carrying Green Fluorescent Gene and Viral Titer Determination].

A doubly auxotrophic CHO‐K1 cell line for the production of recombinant monoclonal antibodies

Exploration of BAC versus plasmid expression vectors in recombinant CHO cells

CRISPR‐interceded CHO Cell Line Development approaches

The new frontier in CHO cell line development: From random to targeted transgene integration technologies

A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors

Establishment of a novel stable human suspension packaging cell line producing ecotropic retroviral MLV(PVC-211) vectors efficiently transducing murine hematopoietic stem and progenitor cells

Construction of a stable expression HEK293T engineered cell line adapted to high-density suspension culture

High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch

Weak promoters to drive selection marker expression: Improvement of cell line development process for therapeutic protein production in CHO-K1 cells